TMO - Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
As of May 15, 2026: spot at $437.94, ATM IV 30.9%, max pain $450.00, net GEX -$21.7M.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Market Cap
- $165.75B
- P/E Ratio
- 24.19
- Beta
- 0.88
- 52-Week Range
- 385.46-643.99
- Dividend Yield
- $1.76
- CEO
- Marc N. Casper
- Employees
- 125,000
- IPO Date
- Mar 17, 1980
- Exchange
- NYSE
What TMO Looks Like to Options Traders Today
IV rank of 45.0% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; negative net gamma exposure (-$21.7M) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.027) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The TMO overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked TMO overview questions
- What is TMO?
- TMO is the ticker symbol for Thermo Fisher Scientific Inc., a listed security. Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. Listed on NYSE. TMO is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the TMO options snapshot look like today?
- As of May 15, 2026, the TMO options snapshot shows spot at $437.94, ATM IV 30.9%, IV rank 45.0%, max pain $450.00, net GEX -$21.7M, expected move 8.87%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are TMO's key statistics?
- Thermo Fisher Scientific Inc. (TMO) carries a market capitalization of $165.75B, trailing P/E ratio of 24.19, beta of 0.88 relative to the broader market, 52-week range of 385.46-643.99. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does TMO belong to?
- Thermo Fisher Scientific Inc. operates in the Healthcare sector, in the Medical - Diagnostics & Research industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare TMO's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the TMO data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).